Citations

Clear

1031 citation(s) found for "Clark, AS".

Safety and efficacy of (+)‐epicatechin in subjects with Friedreich's ataxia: A phase II , open‐label, prospective study
Qureshi, M. Yasir , Clark, Vicki M., Johnson, Jonathan N. , Moutvic, Margaret A., Driscoll, Sherilyn W. , Kemppainen, Jennifer L., Badley, Andrew D. , Tebben, Peter J. , Wackel, Philip L. , Oglesbee, Devin , Glockner, James F., Schreiner, George F., Touchette, Jillienne C. , Gavrilova, Ralitza H. , Qureshi, Muhammad Yasir, Patterson, Marc C. , Clark, Vicki, Anderson, Jeff R , Glockner, James, Qureshi, Muhammad Y , Oglesbee, Devin , Badley, Andrew D , Tebben, Peter , Huston, John , Anderson, Jeff R., Dugar, Sundeep

Mayo Clinic

Journal of Inherited Metabolic Disease | July 17, 2020 | Volume: 44 | Issue: 2 | Pages: 502-514

10.1002/jimd.12285 | PMID 32677106 Get It

Abstract Background (+)‐Epicatechin (EPI) induces mitochondrial biogenesis and antioxidant metabolism in muscle fibers and neurons. We aimed to evaluate safety and efficacy of (+)‐EPI in pediatric subjects with Friedreich's ataxia (FRDA). Methods This was a phase II, open‐label, baseline‐controlled single‐center trial including 10 participants ages 10 to 22 with confirmed FA diagnosis. (+)‐EPI was administered orally at 75 mg/d for 24 weeks, with escalation to 150 mg/d at 12 weeks for subjects not showing improvement of neuromuscular, neurological or cardiac endpoints. Neurological endpoints were change from baseline in Friedreich's Ataxia Rating Scale (FARS) and 8‐m timed walk. Cardiac endpoints were changes from baseline in left ventricular (LV) structure and function by cardiac magnetic resonance imaging (MRI) and echocardiogram, changes in cardiac electrophysiology, and changes in biomarkers for heart failure and hypertrophy. Results Mean FARS/modified (m)FARS scores showed nonstatistically significant improvement by both group and individual analysis. FARS/mFARS scores improved in 5/9 subjects (56%), 8‐m walk in 3/9 (33%), 9‐peg hole test in 6/10 (60%). LV mass index by cardiac MRI was significantly reduced at 12 weeks ( P = .045), and was improved in 7/10 (70%) subjects at 24 weeks. Mean LV ejection fraction was increased at 24 weeks ( P = .008) compared to baseline. Mean maximal septal thickness by echocardiography was increased at 24 weeks ( P = .031). There were no serious adverse events. Conclusion (+)‐EPI was well tolerated over 24 weeks at up to 150 mg/d. Improvement was observed in cardiac structure and function in subset of subjects with FRDA without statistically significant improvement in primary neurological outcomes. Synopsis A (+)‐epicatechin showed improvement of cardiac function, nonsignificant reduction of FARS/mFARS scores, and sustained significant upregulation of muscle‐regeneration biomarker follistatin.
Healthy eating in a Boys & Girls Club afterschool programme: Barriers, facilitators and opportunities
Brockman, Tabetha A. , Sim, Leslie , Biggs, Bridget K. , Bronars, Carrie, Tolleson, Ellen, Asiedu, Gladys B. , Hanza, Marcelo M., Olson, Molly A, Slowiak, Kathleen A, Weis, Jennifer A., Clark, Matthew M. , Millerbernd, Jodi, Sia, Irene G. , Biggs, Bridget K , Sia, Irene G , Brockman, Tabetha A , Meiers, Sonja J. , Ridgeway, Jennifer L. , Patten, Christi A. , Wieland, Mark L.

Mayo Clinic

Health Education Journal | July 10, 2020 | Volume: 79 | Issue: 8 | Pages: 914-931

10.1177/0017896920936722 Get It

Objective: To determine intervention needs and to gather stakeholder input regarding healthy eating promotion for youth members served at a Boys & Girls Club in Rochester, Minnesota. Design: Mixed-methods design informed by community-based participatory research principles. Setting and Method: Young people completed a dietary habits questionnaire and height and weight measure-ments. Focus groups gathered stakeholder – Boys & Girls Club members, staff, caregivers – perspectives on opportunities to improve children’s healthy eating through the club setting. Content analysis identified major themes in informants’ accounts. Results: Participants identified individual and environmental barriers to healthy eating and opportunities to reduce barriers at this Boys & Girls Club site. Few children met basic nutritional guidelines related to fruit, vegetable, milk and water consumption, and limiting consumption of sugar-sweetened beverages, and nearly half were overweight/obese. Stakeholders expressed interest in healthy eating promotion and identified multiple individual-level, interpersonal and environmental opportunities to promote healthier eating through the Boys & Girls Club site. Conclusion: Findings build on a growing literature indicating afterschool programmes are uniquely positioned to address health disparities related to paediatric nutrition and obesity, and can be used to inform the design of a multi-layered intervention to address the complexities influencing dietary quality and obesity among diverse and underserved youth.
Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies
Singleton, Kyle , Porter, Alyx B. , Hu, Leland , Johnston, Sandra K. , Bond, Kamila M. , Rickertsen, Cassandra , León, Gustavo De , Whitmire, Scott A., Clark-Swanson, Kamala , Mrugała, Maciej M. , Swanson, Kristin R. , Singleton, Kyle W , Rickertsen, Cassandra R, De Leon, Gustavo, Clark-Swanson, Kamala R., Swanson, Kristin R , Leon, Gustavo De

Mayo Clinic

Neuro-Oncology Advances | July 9, 2020 | Volume: 2 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdaa085 | PMID 32864609 Get It

Abstract Background Accurate assessments of patient response to therapy are a critical component of personalized medicine. In glioblastoma (GBM), the most aggressive form of brain cancer, tumor growth dynamics are heterogenous across patients, complicating assessment of treatment response. This study aimed to analyze days gained (DG), a burgeoning model-based dynamic metric, for response assessment in patients with recurrent GBM who received bevacizumab-based therapies. Methods DG response scores were calculated using volumetric tumor segmentations for patients receiving bevacizumab with and without concurrent cytotoxic therapy (N = 62). Kaplan–Meier and Cox proportional hazards analyses were implemented to examine DG prognostic relationship to overall (OS) and progression-free survival (PFS) from the onset of treatment for recurrent GBM. Results In patients receiving concurrent bevacizumab and cytotoxic therapy, Kaplan–Meier analysis showed significant differences in OS and PFS at DG cutoffs consistent with previously identified values from newly diagnosed GBM using T1-weighted gadolinium-enhanced magnetic resonance imaging (T1Gd). DG scores for bevacizumab monotherapy patients only approached significance for PFS. Cox regression showed that increases of 25 DG on T1Gd imaging were significantly associated with a 12.5% reduction in OS hazard for concurrent therapy patients and a 4.4% reduction in PFS hazard for bevacizumab monotherapy patients. Conclusion DG has significant meaning in recurrent therapy as a metric of treatment response, even in the context of anti-angiogenic therapies. This provides further evidence supporting the use of DG as an adjunct response metric that quantitatively connects treatment response and clinical outcomes.
Imaging-Based Tissue Heterogeneity to Predict Disease Extent in IPF
John, Joyce , Bartholmai, B., Levin, David L. , King, C., Wilsher, Margaret , Milne, David , Kenneth, Wang Qing, Clark, Alys Rachel , Kumar, Haribalan , Tawhai, Merryn Howatson

Mayo Clinic

A23. ILD PROGNOSIS AND BIOMARKERS I | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A1082-A1082

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1082 Get It

Associations of gastric volumes, ingestive behavior, calorie and volume intake, and fullness in obesity
Vijayvargiya, Priya , Chedid, Victor , Atieh, Jessica , Maselli, Daniel B. , Burton, Duane D. , Clark, Matthew M. , Camilleri, Michael , Maselli, Daniel, Camilleri, M , Chedid, Victor G , Wang, Xiao‐Jing , Acosta, Andrés

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | July 6, 2020 | Volume: 319 | Issue: 2 | Pages: G238-G244

10.1152/ajpgi.00140.2020 | PMID 32628074 Get It

Buffet meal intake was inversely related to the ability to resist the urge to overeat. Factors associated with ingestive behavior significantly correlated with satiety and gastric accommodation. Gastric capacity during fasting is associated with calorie intake to the point of comfortable fullness; factors associated with ingestive behavior are associated with satiety and gastric accommodation.
The Role of the Centrosome in Development and Progression of Breast Cancer
Lingle, Wilma L., Salisbury, J L, Barrett, Susan L., Negron, Vivian , Whitehead, Clark M.

Mayo Clinic

Microscopy and Microanalysis | July 2, 2020 | Volume: 7 | Issue: S2 | Pages: 582-583

10.1017/s1431927600028981 Get It

Abstract The centrosome is the major microtubule organizing center in most mammalian cells, and as such it determines the number, polarity, and spatial distribution of microtubules (MTs). Interphase MTs, together with actin and intermediate filaments, constitute the cell's cytoskeleton, which dynamically maintains cell polarity and tissue architecture. Interphase cells begin Gl of the cell cycle with one centrosome. During S phase, the centrosome duplicates concomitantly with DNA replication. Duplicated centrosomes usually remain in close proximity to one another until late G2, at which time they separate and then move during prophase to become the poles that organize the bipolar mitotic spindle. During the G2/M transition, interphase MTs depolymerize and a new population of highly dynamic mitotic MTs are nucleated at the spindle poles. The bipolar mitotic spindle apparatus constitutes the machinery that partitions and separates sister chromatids equally between two daughter cells.
Clinical Characteristics and Overall Survival in Patients with Anaplastic Pancreatic Cancer
Arun, Janani S., Zhang, Lizhi , Farnell, Michael B., Reid–Lombardo, Kaye M., Clark, Clancy J. , Graham, Rondell P.

Mayo Clinic

The American Surgeon™ | June 17, 2020 | Volume: 80 | Issue: 2 | Pages: 117-123

10.1177/000313481408000218 Get It

Anaplastic pancreatic cancer (APC) is a rare undifferentiated variant of pancreatic ductal adenocarcinoma with poor overall survival (OS). The aim of this study was to evaluate the clinical outcomes of APC compared with differentiated pancreatic ductal adenocarcinoma. We conducted a retrospective review of all patients treated at the Mayo Clinic with pathologically confirmed APC from 1987 to 2011. After matching with control subjects with pancreatic ductal adenocarcinoma, OS was evaluated using Kaplan-Meier estimates and log-rank test. Sixteen patients were identified with APC (56.3% male, median age 57 years). Ten patients underwent exploration of whom eight underwent pancreatectomy. Perioperative morbidity was 60 per cent with no mortality. The median OS was 12.8 months. However, patients with APC who underwent resection had longer OS compared with those who were not resected, 34.1 versus 3.3 months ( P = 0.001). After matching age, sex, tumor stage, and year of operation, the median OS was similar between patients with APC and those with ductal adenocarcinoma treated with pancreatic resection, 44.1 versus 39.9 months, ( P = 0.763). Overall survival for APC is poor; however, when resected, survival is similar to differentiated pancreatic ductal adenocarcinoma.
Barriers to accepting mental health care in cancer patients with depression
Niazi, Shehzad K. , Vargas, Emily , Spaulding, Aaron , Gustetic, Elaine, Ford, Nancy, Paly, David, Tatum, Kelsey, Clark, Matthew M. , Rummans, Teresa A. , Brennan, Emily , Niazi, Shehzad, Rummans, Teresa, Spaulding, Aaron , Ford, Nancy

Mayo Clinic

Social Work in Health Care | June 15, 2020 | Volume: 59 | Issue: 6 | Pages: 351-364

10.1080/00981389.2020.1769248 | PMID 32536332 Get It

Signal quality and patient experience with wearable devices for epilepsy management
Nasseri, Mona , Nurse, Ewan S. , Glasstetter, Martin , Böttcher, Sebastian , Gregg, Nicholas M. , Nandakumar, Aiswarya Laks, Joseph, Boney , Attia, Tal Pal , Viana, Pedro F. , Bruno, Elisa , Biondi, Andrea , Cook, Mark , Schulze‐Bonhage, Andreas , Richardson, Mark P. , Brinkmann, Benjamin H. , Nurse, Ewan , Pal Attia, Tal , Schulze-Bonhage, Andreas , Dümpelmann, Matthias , Brinkmann, Benjamin H , Richardson, Mark P , Cook, Mark J , Joseph, Boney , Biondi, Andrea , Gregg, Nicholas M , Viana, Pedro F , Bruno, Elisa , Worrell, Gregory A. , Dümpelmann, Matthias , Freestone, Dean R.

Mayo Clinic

Epilepsia | June 4, 2020 | Volume: 61 | Issue: S1 | Pages: No page available

10.1111/epi.16527 | PMID 32497269 Get It

Abstract Noninvasive wearable devices have great potential to aid the management of epilepsy, but these devices must have robust signal quality, and patients must be willing to wear them for long periods of time. Automated machine learning classification of wearable biosensor signals requires quantitative measures of signal quality to automatically reject poor‐quality or corrupt data segments. In this study, commercially available wearable sensors were placed on patients with epilepsy undergoing in‐hospital or in‐home electroencephalographic (EEG) monitoring, and healthy volunteers. Empatica E4 and Biovotion Everion were used to record accelerometry (ACC), photoplethysmography (PPG), and electrodermal activity (EDA). Byteflies Sensor Dots were used to record ACC and PPG, the Activinsights GENEActiv watch to record ACC, and Epitel Epilog to record EEG data. PPG and EDA signals were recorded for multiple days, then epochs of high‐quality, marginal‐quality, or poor‐quality data were visually identified by reviewers, and reviewer annotations were compared to automated signal quality measures. For ACC, the ratio of spectral power from 0.8 to 5 Hz to broadband power was used to separate good‐quality signals from noise. For EDA, the rate of amplitude change and prevalence of sharp peaks significantly differentiated between good‐quality data and noise. Spectral entropy was used to assess PPG and showed significant differences between good‐, marginal‐, and poor‐quality signals. EEG data were evaluated using methods to identify a spectral noise cutoff frequency. Patients were asked to rate the usability and comfort of each device in several categories. Patients showed a significant preference for the wrist‐worn devices, and the Empatica E4 device was preferred most often. Current wearable devices can provide high‐quality data and are acceptable for routine use, but continued development is needed to improve data quality, consistency, and management, as well as acceptability to patients.